Abbott reports Q2 worldwide Medical Devices sales up 13.5% on reported basis

Worldwide Medical Devices sales increased 13.5% on a reported basis and 14.2% on an organic basis in the second quarter. Sales growth was led by double-digit organic growth in Diabetes Care, Electrophysiology, Structural Heart and Neuromodulation. Several recently launched products and new indications contributed to the strong performance, including Amplatzer Amulet, Navitor, TriClip, and Aveir. In Electrophysiology, internationally, sales grew high-teens on a reported basis and more than 20% on an organic basis, which includes high-teens growth in Europe. In Diabetes Care, FreeStyle Libre sales were $1.3B, which represents sales growth of 22.9% on a reported basis and 24.7% on an organic basis.